Dr. Peter Kilmarx Appointed Deputy Director of Fogarty International Center
News Aug 12, 2015
Peter Kilmarx, M.D., an expert in infectious disease research and HIV/AIDS prevention, has been named Deputy Director of the Fogarty International Center at the National Institutes of Health.
Dr. Kilmarx previously served as the Center for Disease Control and Prevention's Country Director in Zimbabwe, providing oversight for 30 CDC staff who managed implementation of the U.S. efforts to reduce HIV/AIDS, TB and malaria.
"I am delighted to welcome Dr. Kilmarx to Fogarty," said Dr. Roger I. Glass, Fogarty Director. "His background leading clinical trials and programs overseas -- combined with his management expertise -- make him the ideal candidate to help the center advance international collaborations, boost its research and training programs, and prepare the next generation of global health research leaders."
A captain in the U.S. Public Health Service, Dr. Kilmarx served as the CDC Ebola response team leader in Sierra Leone in September-October 2014, and as principal deputy team leader in Guinea in January-February 2015.
Previously, he initiated the CDC response to the Ebola outbreak in Kasai Occidental, Democratic Republic of Congo (DRC), in 2007, and led household surveillance in the Ebola outbreak in Kikwit, DRC, in 1995.
Dr. Kilmarx has held a variety of leadership positions at the CDC since 1996, including senior advisor to the Director for Health Reform and chief of the Epidemiology Branch - both in the Division of HIV/AIDS Prevention. He also served as director of the CDC partnership with Botswana to combat HIV/AIDS, TB and related conditions, as well as the chief of the CDC's Sexual Transmission Research Section in Thailand.
Previously, he completed assignments in Pakistan and the DRC. An experienced clinical trials manager, he has served as principal investigator on microbicide trials in Thailand, and as senior investigator in TB and HIV trials in Botswana. Until recently, he was principal investigator on HIV studies he initiated at public health facilities in Zimbabwe.
"I am excited to assume this new role, which will allow me to draw on my first-hand knowledge of the research questions facing health officials in low- and middle-income countries to strengthen Fogarty's innovative programs," said Dr. Kilmarx. "By cultivating in-country research expertise, we can empower low and middle-income countries to investigate their nation's most pressing health issues so they can most effectively improve the health of their people."
After earning his M.D. from Dartmouth-Brown's Combined Program in Medicine, Dr. Kilmarx completed both his internal medicine residency and infectious disease clinical fellowship at Johns Hopkins Hospital, Baltimore. He remains board-certified in both specialties and is a fellow of the Infectious Diseases Society of America and of the American College of Physicians. He has published numerous peer-reviewed journal articles and book chapters, and serves on the editorial board of Sexually Transmitted Diseases.
He began his international career as a Peace Corps volunteer in the DRC (then Zaire), where he helped develop fisheries that are still productive.
Huntsman Cancer Institute Joins National Clinical Trial Targeting AMLNews
Huntsman Cancer Institute (HCI) at the University of Utah (U of U) has been selected to participate in the Beat AML Master Trial, an innovative clinical trial sponsored by The Leukemia & Lymphoma Society (LLS). The clinical trial is testing several new targeted therapies for the treatment of patients with acute myeloid leukemia (AML). HCI is the only facility in the Mountain West offering this trial to AML patients.READ MORE
Study Extends Potential of Personalized Cell-based ImmunotherapiesNews
New methods developed for the study could be applied to devise personalized, cell-based immunotherapies for epithelial ovarian cancer or other types of tumorsREAD MORE
Comments | 0 ADD COMMENT
World Congress on Advanced Pharmacy and Clinical Research
Jul 16 - Jul 17, 2018
World Congress on Pathology and Laboratory Medicine
Sep 10 - Sep 11, 2018
International Conference on Molecular Biology and Stem Cells
Aug 13 - Aug 15, 2018